KARLIN DAVID Aofficer: VP, Clinical Researchofficer: VP, Clinical Research
Common Stock
2,000
$2.73
$5,460
Sale
CHANDLER JOHN Jofficer: VP, Corporate Developmentofficer: VP, Corporate Developm..
Common Stock
3,200
$2.63
$8,416
Option
KARLIN DAVID Aofficer: VP, Clinical Researchofficer: VP, Clinical Research
Employee Stock Option (right to buy)
2,000
$1.92
$3,840
Option
KARLIN DAVID Aofficer: VP, Clinical Researchofficer: VP, Clinical Research
Common Stock
2,000
$1.92
$3,840
Sale
JUELIS A RICHARDofficer: Vice Presidentofficer: Vice President
Common Stock
12,200
$4.97
$60,671
Sale
KARLIN DAVID Aofficer: VP, Clinical Researchofficer: VP, Clinical Research
Common Stock
6,000
$4.42
$26,496
Sale
KARLIN DAVID Aofficer: VP, Clinical Researchofficer: VP, Clinical Research
Common Stock
3,000
$4.99
$14,955
Sale
JUELIS A RICHARDofficer: Vice Presidentofficer: Vice President
Common Stock
14,500
$4.94
$71,558
Sale
KARLIN DAVID Aofficer: VP, Clinical Researchofficer: VP, Clinical Research
Common Stock
11,000
$4.96
$54,516
Sale
KARLIN DAVID Aofficer: VP, Clinical Researchofficer: VP, Clinical Research
Common Stock
3,000
$5
$15,000
Sale
KARLIN DAVID Aofficer: VP, Clinical Researchofficer: VP, Clinical Research
Common Stock
4,000
$5
$20,000
Sale
JUELIS A RICHARDofficer: Vice Presidentofficer: Vice President
Common Stock
2,100
$4.76
$10,002
Sale
JUELIS A RICHARDofficer: Vice Presidentofficer: Vice President
Common Stock
2,000
$5
$10,000
Sale
KARLIN DAVID Aofficer: VP, Clinical Researchofficer: VP, Clinical Research
Common Stock
4,900
$5.01
$24,534
Sale
KARLIN DAVID Aofficer: VP, Clinical Researchofficer: VP, Clinical Research
Common Stock
5,000
$5.17
$25,850
Option
JUELIS A RICHARDofficer: Vice Presidentofficer: Vice President
Employee Stock Option (right to buy)
33,520
$0.9
$30,168
Option
JUELIS A RICHARDofficer: Vice Presidentofficer: Vice President
Common Stock
33,520
$1.8
$60,336
Sale
KARLIN DAVID Aofficer: VP, Clinical Researchofficer: VP, Clinical Research
Common Stock
10,000
$4.8
$48,000
Option
KARLIN DAVID Aofficer: VP, Clinical Researchofficer: VP, Clinical Research
Employee Stock Option(right to buy)
20,000
$1.92
$38,400
Option
KARLIN DAVID Aofficer: VP, Clinical Researchofficer: VP, Clinical Research
Common Stock
20,000
$1.92
$38,400
Purchase
ADAMS JOHN Qdirectordirector
Common Stock
6,400
$3.61
$23,085
Purchase
ADAMS JOHN Qdirectordirector
Common Stock
600
$3.67
$2,202
Purchase
TISCH ANDREW H10 percent owner10 percent owner
Common Stock
150,000
$3.42
$512,850
Purchase
TISCH JAMES S10 percent owner10 percent owner
Common Stock Warrants (right to buy)
30,000
$4.62
$138,600
Purchase
TISCH JAMES S10 percent owner10 percent owner
Common Stock
150,000
$3.42
$512,850
Purchase
TISCH THOMAS J10 percent owner10 percent owner
Common Stock Warrants (right to buy)
30,000
$4.62
$138,600
Purchase
TISCH THOMAS J10 percent owner10 percent owner
Common Stock
150,000
$3.42
$512,850
Purchase
TISCH DANIEL R10 percent owner10 percent owner
Common Stock
150,000
$3.42
$512,850
Purchase
GREGORY JOHN M10 percent owner10 percent owner
Warrants to purchase shares
200,000
$4.62
$924,000
Purchase
GREGORY JOHN M10 percent owner10 percent owner
Common Stock
1,000,000
$3.42
$3,419,000
Purchase
TISCH ANDREW H10 percent owner10 percent owner
Common Stock Warrants (right to buy)
30,000
$4.62
$138,600
Purchase
TISCH DANIEL R10 percent owner10 percent owner
Common Stock Warrants (right to buy)
30,000
$4.62
$138,600
Purchase
ROTHERMEL ROBERT Bdirectordirector
Common Stock
5,000
$5.95
$29,750
Purchase
GREGORY JOHN M10 percent owner10 percent owner
Common Stock
189,656
$6.08
$1,152,540
Purchase
GREGORY JOHN M10 percent owner10 percent owner
Common Stock
500,000
$5.85
$2,927,000
Purchase
GREGORY JOHN M10 percent owner10 percent owner
Common Stock
255,007
$5.86
$1,495,361
Purchase
ADAMS JOHN Qdirectordirector
Common Stock
3,000
$2.89
$8,670
Purchase
WILLIAMS RICHARD Cdirectordirector
Common Stock
8,000
$2.8
$22,360
Purchase
WILLIAMS RICHARD Cdirectordirector
Common Stock
2,000
$2.74
$5,480
Showing 150 to 193 of 193 results.
Insider trading
Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.
Who is insider?
Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.
